Monday, January 22, 2018

Celgene to Buy Juno Therapeutics for $9 Billion

Celgene said it agreed to buy Juno Therapeutics for $87 a share in cash, or about $9 billion, in a move that will expand Celgene’s portfolio of blood-cancer drugs.

from WSJ.com: US Business http://ift.tt/2rsyXEB
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)